Becton, Dickinson and Company B1DX34.SA Stock
Becton, Dickinson and Company Price Chart
Becton, Dickinson and Company B1DX34.SA Financial and Trading Overview
Becton, Dickinson and Company stock price | 241.5 BRL |
Previous Close | 265.46 BRL |
Open | 0 BRL |
Bid | 271.89 BRL x N/A |
Ask | 274.32 BRL x N/A |
Day's Range | 0 - 0 BRL |
52 Week Range | 0 - 273.75 BRL |
Volume | 0 BRL |
Avg. Volume | 14 BRL |
Market Cap | 405.04B BRL |
Beta (5Y Monthly) | 0.593349 |
PE Ratio (TTM) | 49.456364 |
EPS (TTM) | 4.44 BRL |
Forward Dividend & Yield | 3.68 (1.37%) |
Ex-Dividend Date | June 7, 2023 |
1y Target Est | N/A |
B1DX34.SA Valuation Measures
Enterprise Value | 400.91B BRL |
Trailing P/E | 49.456364 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 21.266653 |
Price/Book (mrq) | 15.212407 |
Enterprise Value/Revenue | 21.05 |
Enterprise Value/EBITDA | 82.272 |
Trading Information
Becton, Dickinson and Company Stock Price History
Beta (5Y Monthly) | 0.593349 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 273.75 BRL |
52 Week Low | 0 BRL |
50-Day Moving Average | 256.37 BRL |
200-Day Moving Average | 255.65 BRL |
B1DX34.SA Share Statistics
Avg. Volume (3 month) | 14 BRL |
Avg. Daily Volume (10-Days) | 0 BRL |
Shares Outstanding | 1.42B |
Float | 1.45B |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 3.6 |
Trailing Annual Dividend Yield | 1.35% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.6386 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | September 30, 2022 |
Most Recent Quarter (mrq) | June 30, 2023 |
Next Fiscal Year End | September 30, 2023 |
Profitability
Profit Margin | 8.73% |
Operating Margin (ttm) | 13.60% |
Gross Margin | 45.56% |
EBITDA Margin | 25.58% |
Management Effectiveness
Return on Assets (ttm) | 3.04% |
Return on Equity (ttm) | 6.47% |
Income Statement
Revenue (ttm) | 19.05B BRL |
Revenue Per Share (ttm) | 13.38 BRL |
Quarterly Revenue Growth (yoy) | 5.09% |
Gross Profit (ttm) | 8.61B BRL |
EBITDA | 4.87B BRL |
Net Income Avi to Common (ttm) | 1.58B BRL |
Diluted EPS (ttm) | 5.5 |
Quarterly Earnings Growth (yoy) | 13.10% |
Balance Sheet
Total Cash (mrq) | 931M BRL |
Total Cash Per Share (mrq) | 0.64 BRL |
Total Debt (mrq) | 16.78B BRL |
Total Debt/Equity (mrq) | 64.7 BRL |
Current Ratio (mrq) | 1.249 |
Book Value Per Share (mrq) | 17.8808 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.77B BRL |
Levered Free Cash Flow (ttm) | 1.93B BRL |
Profile of Becton, Dickinson and Company
Country | Brazil |
State | NJ |
City | Franklin Lakes |
Address | 1 Becton Drive |
ZIP | 07417-1880 |
Phone | 201 847 6800 |
Website | https://www.bd.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 77000 |
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Q&A For Becton, Dickinson and Company Stock
What is a current B1DX34.SA stock price?
Becton, Dickinson and Company B1DX34.SA stock price today per share is 241.5 BRL.
How to purchase Becton, Dickinson and Company stock?
You can buy B1DX34.SA shares on the São Paulo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Becton, Dickinson and Company?
The stock symbol or ticker of Becton, Dickinson and Company is B1DX34.SA.
Which industry does the Becton, Dickinson and Company company belong to?
The Becton, Dickinson and Company industry is Medical Instruments & Supplies.
How many shares does Becton, Dickinson and Company have in circulation?
The max supply of Becton, Dickinson and Company shares is 1.44B.
What is Becton, Dickinson and Company Price to Earnings Ratio (PE Ratio)?
Becton, Dickinson and Company PE Ratio is 54.39189000 now.
What was Becton, Dickinson and Company earnings per share over the trailing 12 months (TTM)?
Becton, Dickinson and Company EPS is 4.44 BRL over the trailing 12 months.
Which sector does the Becton, Dickinson and Company company belong to?
The Becton, Dickinson and Company sector is Healthcare.